NGM BIOPHARMACEUTICALS INC - COM (NGM)

CUSIP: 62921N105

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM
Total 13F shares
47,286,277
Share change
-742,376
Total reported value
$50,601,674
Put/Call ratio
75%
Price per share
$1.07
Number of holders
91
Value change
-$2,234,506
Number of buys
41
Number of sells
57

Quarterly Holders Quick Answers

What is CUSIP 62921N105?
CUSIP 62921N105 identifies NGM - NGM BIOPHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NGM BIOPHARMACEUTICALS INC - COM (NGM) as of Q3 2023

As of 30 Sep 2023, NGM BIOPHARMACEUTICALS INC - COM (NGM) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,286,277 shares. The largest 10 holders included Column Group LLC, EcoR1 Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, StepStone Group LP, JPMORGAN CHASE & CO, ACADIAN ASSET MANAGEMENT LLC, Euclidean Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 91 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.